CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 target
Drug / intervention
Expiratory positive airway pressure (EPAP) by face mask.device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01111487
NCT01111487N/ACompleted
CompareCT.gov

Inspiratory Muscle Recruitment in COPD Patients With the Use of Expiratory Positive Airways Pressure

Hospital de Clinicas de Porto Alegre·interventional·Posted Apr 27, 2010·Updated Sep 27, 2011

In Brief

A clinical study evaluating Expiratory positive airway pressure (EPAP) by face mask. for Chronic Obstructive Pulmonary Disease (COPD). Completed, enrolled 40 participants across 3 sites.

Detailed Summary

The objective is to evaluate whether the use of expiratory positive airway pressure (EPAP) reduces the electrical activity of the sternocleidomastoid muscle and enhances the action of the muscle in the patient parasternal ported from Chronic Obstructive Pulmonary Disease. Noting also, if the set pressure level (10 or 15 cmH2O) affects this relationship.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Obstructive Pulmonary Disease (COPD)
CountriesBrazil
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 27, 2010
Enrollment StartNov 1, 2009
Primary CompletionAug 1, 2011
Study CompletionSep 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 16.2 years ago

Interventions

Expiratory positive airway pressure (EPAP) by face mask.device

Implementation of the EPAP as group pressure, 10 or 15 cmH2O, for 20 minutes then evaluated the electromyographic activity of muscles and sternocleidomastoid parasternal the tenth and twentieth minutes of your application.